Basic Information
Dementia & Neuropsychologia is a journal of the Academia Brasileira de Neurologia (Brazilian Academy of Neurology) whose mission is to contribute to the advancement of scientific knowledge in the areas of cognitive and behavioral sciences, through the publication of peer-reviewed articles. Dementia & Neuropsychologia is a quarterly journal published in English which also includes Portuguese versions of the title, abstract and key words. The journal was also printed until issue 14 (2020). Since then, it has only been available online, in open access format.
|
Indexed sources
|
Intellectual Property
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type CC-BY. |
Editor-in-Chief
|
Co-Editors
|
Consultive Board
|
Associate editors
Behavioral disorders in dementia
Biomarkers in dementia diagnosis
Mild cognitive impairment
Caregiver: stress and orientation
Cognition and Aging
Dementia costs
Lewy Body Dementia/ Parkinson Disease/Atypical parkinsonism
Frontotemporal Dementia
Vascular Dementia
Epidemiology
Clinical Trials
Genetics
Neuroimaging
Neuroimaging through Clinical cases
Language and Aphasia
Neuropathology
Developmental Neuropsychology
Neuropsychology: diagnostic tests
History Note
Rehabilitation
Subjective cognitive decline
Translation and Transcultural Validation
Social Media and Visual Abstract Editors
|
Executive Office
|
Publishing Services
|
Scope and Policy
Dementia & Neuropsychology is to publish research in cognitive and behavioral sciences, focusing on clinical epidemiology, basic and applied neurosciences, and cognitive tests devised or adapted for populations with heterogeneous cultural, educational, and socioeconomic backgrounds. Dementia & Neuropsychology is particularly involved in publishing and disseminating research findings relevant to developing countries. It also seeks to disseminate reviews and case reports that are important contributions to field of cognitive neuroscience. The journal follows the guidelines of the International Committee of Medical Journal Editors – ICMJE entitled Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/recommendations/), update December 2019.
The journal follows the code of ethical conduct in publication, recommended by the Committee on Publication Ethics – COPE (http://publicationethics.org). Authorship To be included as an author it is expected that the person has made a significant intellectual contribution to the manuscript submitted to Dementia & Neuropsychology. As recommended by the International Committee of Medical Journal Editors (ICMJE), authorship is based on the following criteria:
• Substantial contribution to the design of the study project or to the acquisition, analysis and interpretation of data;
The full text of the ICMJE recommendations are available at: Conflict of interest A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships that could inappropriately influence (or bias) the author's decisions, work, or manuscript. Authors are expected to provide detailed information about any relevant financial interests or financial conflicts within the past 5 years and for the foreseeable future, particularly those present at the time the research was conducted and up to the time of publication. In addition, authors who have no relevant financial interests are asked to provide a statement indicating that they have no financial interests related to the material in the manuscript. Authors are required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies. The policy requesting disclosure of conflicts of interest applies to all manuscript submissions, including letters to the editor and case reports. Informed consent For experimental investigations involving human or animal subjects, state in the "Methods" section of the manuscript that an appropriate institutional review board has approved the project. A copy of the approval by the Ethics Committee should be mailed with the manuscript. For those investigators who do not have access to a formal ethics review committee (institutional or regional), the principles outlined in the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) should be followed. For investigations of human subjects, state in the "Methods" section the manner in which informed consent was obtained from the subjects. A letter of consent must accompany all photographs of patients in which a possibility of identification exists. It is not sufficient to cover the eyes to mask identity. Refer to patients by number (or in anecdotal reports, by assigning fictitious names). Real names or initials should not be used in the text, tables, or illustrations. Duplicate previous publication or submission Manuscripts are received on the understanding that they are not under simultaneous consideration by another journal or title. This information must be included in the cover letter. Dementia & Neuropsychologia uses tools for detecting possible text similarity to check for plagiarism. When plagiarism is detected, the journal follows the Core Practices of the Committee on Publication Ethics - COPE (http://publicationethics.org/). Clinical trials In concert with the International Committee of Medical Journal Editors (ICMJE), Dementia & Neuropsychologia requires, as a precondition to be considered for publication, registration of clinical trials in a public trials registry. Acceptable trial registries include http://clinicaltrials.gov, http://isrctn.org, http://actr.org.au, http://trialregister.nl, and http://www.umin.ac.jp/ctr. For this purpose, the ICMJE defines a clinical trial as any study that prospectively assigns human subjects to intervention or comparison groups to evaluate the cause-and-effect relationships between a medical intervention and a health outcome. The trial registry name, its URL and the registration number should be included at the end of the abstract. Trials must be registered at or before commencement of patient enrollment. In agreement with BIREME/PAHO/WHO recommendations for reporting randomized trials, authors are advised to adhere to the guidelines in the CONSORT STATEMENT (www.consort-statement.org). Funding/support and role of sponsor All financial and material support for the research and work should be clearly and fully identified in the acknowledgment. Data access and responsibility For clinical trials sponsored by pharmaceutical companies, authors must state in their letter of submission that: (1) they have had full access to all the data; (2) they had the right to publish all the data; and (3) they have had the right to obtain independent statistical analyses of the data. Manuscripts containing statistical evaluations should include the name and affiliation of the statistical reviewer. Preprint Dementia & Neuropsychology accepts submission of manuscripts previously deposited in preprint repositories. For submission of deposited manuscripts, the author must indicate the repository data in the Cover Letter. |
Editores-Asociados Form and preparation of manuscripts
Title page. Include manuscript title, running title and authors' names. The title should be concise and descriptive, up to 150 characters (with spaces), carrying essential information on the manuscript content. The name of the authors should include the first name. At the bottom of the title page indicate: the name of the department and institution, up to 100 characters, city and country in which the study was conducted; contribution of each author to or elaborate or manuscript, and ORCID of all authors, the academic title of each author and their institutional affiliation; grant support; acknowledgements; name and address (postal and electronic) for mail. Abstract. The abstract of original manuscripts or short communications should be structured and contain the following items: background, objective(s), methods, results and conclusions. Abstracts may contain up to 250 words. Abstracts of case reports, history notes or reviews may be unstructured and contain up to 150 words.
Key words. Include 4-6 key words in English, according to the DeCS – Descriptors for Health Sciences (http://decs.bvs.br/) or MeSH – Medical Subject Headings (http://www.ncbi.nlm.nih.gov/mesh). Text. Original manuscripts may have up to 3,000 words and contain only four sections: introduction (which usually finishes by defining the objectives); methods (material and/or subjects; statistical methods; bioethical approach with the name of the Ethics Committee that approved the study and patient Informed Consent); results; discussion (which should include the limitations of the study and conclusions); and acknowledgements. Data presented in tables and illustrations should not be repeated in the text. Observations: Short communication, history note and case report: up to 2,000 words of text; reviews up to 5,000 words.”Neuroimaging through clinical cases” up to 750 words. References. Up to 50 references may be included for original manuscripts, numbered consecutively in the order they are cited. For case reports, history note or short communications, up to 30, for “Neuroimaging through clinical cases” up to 20 and for reviews up to 150 references are allowed. In the body of the text, references must be identified with Arabic numerals, in exponent. The presentation of the references is in accordance with the standard defined by the International Committee of Medical Journal Editors - ICMJE (https://www.nlm.nih.gov/bsd/uniform_requirements.html) and the titles of the journals must be abbreviated according to the Medicus Index : journal title abbreviations (http://www2.bg.am.poznan.pl/czasopisma/medicus.php?lang=eng).
Tables. Up to 5 tables are allowed in original manuscripts (up to 3 tables in short communications, history note or case reports), each presented on a separate page together with its title, notes and sequence number. Tables should contain all information required to be understood by the reader. Vertical lines should not be used for separating data within the table. Type each table double spaced on a separate page. Do not submit tables as photographs. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Give each column a short or abbreviated heading. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations used in each table. For footnotes use the following symbols, in this sequence: *, +, §, ||, ¶, **, ++, etc. The editor, on accepting a manuscript, may recommend that additional tables containing important supporting data too extensive to publish be deposited with an archival service, such as the site of the journal (www.demneuropsy.com.br), or be made available by the authors. In this case, an appropriate statement will be added to the text. Submit all tables for consideration together with the manuscript. Illustrations. Up to 4 figures, graphs or photos are allowed, with their title and notes on separate pages (up to 3 illustrations in short communications, history note or case reports). Figures must be submitted in JPEG or TIFF format, with the following resolutions: a) Artwork in black and white: 1,200 dpi/ppi; b) Half-tones: 300 dpi/ppi; c) Combination of half-tones: 600 dpi/ppi. The table below presents a summary of the requirements defined for each type of contribution:
|
Send of the manuscripts
Submissions must be made online: https://mc04.manuscriptcentral.com/dn-scielo. Manuscripts must be written in English, and present title, abstract and keywords in both English and Portuguese. For those who do not write in Portuguese, the editorial office will translate these items. Submissions must be accompanied by a cover letter, declaration of Authorship Responsibility, Financial Disclosure and Copyright Transfer/Publishing Agreement. Studies involving humans should be accompanied by a copy of the Ethics Committee authorization from the institution involved. Clinical trial studies will be accepted for publication, pending the presentation of Clinical Trial Registers. The authors may be asked for additional information regarding previous presentations at Scientific Meetings. This information can be supplied in the cover letter sent at the time of manuscript submission. Note. Before submitting your manuscript, please go through the Author's checklist and complete the Authorship, non-financial, and financial disclosure forms in annex: Authorship Disclosure. There are no fees for manuscript submission or manuscript review. Review Process All submitted manuscripts are reviewed initially by Editors-in-Chief. Manuscripts with insufficient priority for publication are rejected promptly. Initial screening will be performed by one of the Editors-in-Chief to verify the formal eligibility of the manuscript according to the editorial norms Dementia & Neuropsychologia. Submission of manuscripts that do not comply with the format described in this document may incur its return. After approval of formal aspects, the manuscript is submitted to peer-review and to ad-hoc consultants, as well as international and national specialists. Each manuscript is evaluated by at least two reviewers. Based on the reviewers' comments and the Associate Editors' recommendations, the Editors-in-Chief may: a) accept the publication of the manuscript; 2) ask authors to review and resubmit the manuscript – Minor or Major Revision; or c) reject and no longer consider the manuscript for publication. To submit the revised version of the manuscript, authors will have 30 days for a minor review and 60 days for a major review. The entire process is overseen by the Editor-in-Chief who determines the number of appropriate re-submissions, with a focus on the quality of the work being published at all times. Authors will be informed by the Editor-in-Chief of the likely date of publication after their final decision. The journal adopts the double-blind peer-review mode. In this way, peer reviewers’ identities are kept confidential, and authors' identities are also not disclosed to reviewers. |